This website is intended for healthcare professionals only

Trending Topic

Eye Examination with High-Tech Ophthalmology Equipment. Patient undergoing an eye examination using advanced ophthalmology equipment with orange light, for accurate diagnostics.
11 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Hashem  Abu Serhan, Abdullah Ahmed, Barbara Parolini

Ophthalmologists, like all medical professionals, strive to base their practice on solid evidence. However, even in our field, certain beliefs have taken root more through tradition and repetition than through rigorous scientific scrutiny. Margolis and Galor published their editorial in which they debunked six myths related to the anterior segment.1 Their work motivated our critical thinking, […]

Foreword – European Ophthalmic Review, 2016;10(1):13

Maurizio Battaglia Parodi
2 mins
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Aug 9th 2016 European Ophthalmic Review, 2016;10(1):13
Select a Section…
1

Article

Welcome to the latest edition of European Ophthalmic Review, which features a wide range of articles, beginning with intraocular diseases. An editorial from Rodrigues and Lim explores approaches to achieving successful outcomes and minimising complications in neovascular glaucoma surgery. Also on the subject of glaucoma, Feijoo discusses the latest advances in tonometry. Biologic targeted therapies are transforming the treatment of uveitis. Taylor discusses the latest clinical advances in this field.

Optical coherence tomography angiography (OCTA) is an emerging, non-invasive imaging technique that generates three-dimensional images without the need for intravenous dyes. This technology has numerous potential applications for retinal vascular disease. Turgut and Reznicek each present reviews of the advantages and disadvantages of OCTA. In addition, Iuliano describes the application of OCTA to chorodial neovascularisations.

Diabetic macular oedema continues to present a major health challenge worldwide. Augustin presents a review of findings from clinical trials and real-world studies. While clinical trial data have shown comparable outcomes between vascular endothelial growth factor (VEGF) inhibitors and corticosteroids, real-world findings suggest that lower injection frequencies of VEGF are associated with less impressive outcomes. Sustained delivery of corticosteroids has shown similar efficacy in clinical and real-world studies.

Age-related macular degeneration (AMD) is the leading cause of vision loss in the elderly. In an expert review of a symposium presented at the 15th EURETINA Congress, Korobelnik et al discuss the use of aflibercept in AMD, including recent real-world data indicating that aflibercept can be given with reduced dosing frequency.

Finally, Michels and Wirth present an update of the management of branch retinal vein occlusion, including established and emerging treatment options.

European Ophthalmic Review would like to thank our Editorial Board for their continuing support and guidance. A special thanks also goes to our authors, who gave their time and effort to produce an insightful selection of articles. The expert discussions and the range of topics covered ensure there is something of interest for every reader and we hope you find this edition useful.

2

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup